Moneycontrol PRO
UPCOMING EVENT:Watch leaders discuss the biggest issue of our times at the Sustainability 100+ Summit. Register now!

Natco Pharma Q3 PAT may dip 30.3% YoY to Rs. 151.7 cr: ICICI Direct

Net Sales are expected to decrease by 4.9 percent Y-o-Y (down 1.6 percent Q-o-Q) to Rs. 534.7 crore, according to ICICI Direct.

January 11, 2019 / 06:07 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

ICICI Direct has come out with its third quarter (October-December’ 18) earnings estimates for the Healthcare sector. The brokerage house expects Natco Pharma to report net profit at Rs. 151.7 crore down 30.3% year-on-year (down 16.9% quarter-on-quarter).


Net Sales are expected to decrease by 4.9 percent Y-o-Y (down 1.6 percent Q-o-Q) to Rs. 534.7 crore, according to ICICI Direct.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 33.9 percent Y-o-Y (down 14.2 percent Q-o-Q) to Rs. 189.2 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol News

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark